About Famar
Famar is a company based in Athens (Greece) founded in 1949 was acquired by MidEuropa in July 2024. Famar has raised $6.06 million across 3 funding rounds from investors including EBRD, Pillarstone and York Capital. Famar offers products and services including R&D Services, Manufacturing Services, Quality Services, Regulatory Services, and Logistics Services. Famar operates in a competitive market with competitors including Crown Laboratories, Encube Ethicals, Curida, Formulated Solutions and Contract Pharmaceuticals, among others.
- Headquarter Athens, Greece
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Famar Health Care Services
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.06 M (USD)
in 3 rounds
-
Latest Funding Round
$6.06 M (USD), Private Equity Round
Sep 04, 2025
-
Investors
EBRD
& 4 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Famar
Famar offers a comprehensive portfolio of products and services, including R&D Services, Manufacturing Services, Quality Services, Regulatory Services, and Logistics Services.
Services for pharmaceutical product development and innovation
Manufacturing of pharmaceutical and consumer care products
Ensuring compliance and quality in pharmaceutical processes
Handling regulatory requirements for pharmaceutical products
Distribution and logistics for pharmaceutical products
People of Famar
Unlock access to complete
Funding Insights of Famar
Famar has successfully raised a total of $6.06M across 3 strategic funding rounds. The most recent funding activity was a Private Equity Round of $6.06 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Famar
Famar has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include EBRD, Pillarstone and York Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate advisory services are provided across multiple sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
MidEuropa is engaged in private equity investments in Central Europe.
|
Locked | Locked | Locked |
Investor details for Famar
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Famar
Investment portfolio details for Famar
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Famar
Detailed financials for Famar
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Famar Comparisons
Peer comparison for Famar
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Famar
Famar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Crown Laboratories, Encube Ethicals, Curida, Formulated Solutions and Contract Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
OTC, prescription, skin care, and oral care products are manufactured.
|
|
| Locked | Locked | Locked |
Contract development and manufacturing for topical semisolid formulations are provided.
|
|
| Locked | Locked | Locked |
Liquid pharmaceuticals are developed via blow fill seal technology.
|
|
| Locked | Locked | Locked |
Company offering CDMO services for the pharma (Rx and OTC), medical device, personal care and veterinary medicine sectors
|
|
| Locked | Locked | Locked |
CDMO focused on manufacturing of semi-solid pharmaceutical drugs
|
Detailed competitors of Famar
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Famar
Complete news archive for Famar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Famar
Famar was founded in 1949 and raised its 1st funding round 69 years after it was founded.
Famar is headquartered in Athens, Greece.
Famar is a funded company, having raised a total of $6.06M across 3 funding rounds to date.
Famar was founded in 1949 and is based in Athens, Greece. Contract manufacturing and development services are delivered to the pharmaceutical and health beauty sectors. Key operations include product transfers and industrialization, product development, quality assurance, technical RD, manufacturing, analytical method validation, packaging, and logistics.
Famar's top competitors include Encube Ethicals, Crown Laboratories and Formulated Solutions.
Famar offers R&D Services, Manufacturing Services, Quality Services, Regulatory Services, and Logistics Services.
Famar has 5 investors. Key investors include EBRD, Pillarstone, York Capital, Elements Capital Partners, and MidEuropa.